openPR Logo
Press release

2022 Outlook: Big Opportunities for Interventional Cardiology Devices Market in Emerging Nations

02-02-2017 12:53 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

2022 Outlook: Big Opportunities for Interventional Cardiology

Interventional cardiology devices are minimally invasive devices used in the detection and treatment of coronary artery disease. This report on interventional cardiology devices studies the current and future prospects of the market globally. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments included in the study. This section also provides the overall information and data analysis of the global interventional cardiology devices market with respect to the leading market segments based on type of device, technique, and geography.

Get the Upcoming Market Trends of Interventional Cardiology Devices at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=853

The market overview section of the report comprises qualitative analysis of the overall interventional cardiology devices market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces analysis and market attractiveness analysis. In addition, various analyses such as value chain analysis, regulatory framework, market attractiveness analysis by geography and competitive landscape by key players has also been provided. Value chain analysis includes the study of major steps involved in the production and distribution of interventional cardiology devices. Regulatory framework includes the study of different regulatory norms and procedures that regulate the approval and commercialization of interventional cardiology devices and techniques. The market attractiveness analysis is provided in order to explain the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help the market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

The global interventional cardiology devices market has been segmented on the basis of device type, technique, and geography. Based on device type, the interventional cardiology devices market has been categorized into five major segments: stents, catheters, percutaneous transluminal coronary angioplasty (PTCA) balloons, percutaneous transluminal coronary angioplasty (PTCA) guide wires, and other accessories. Stents have been further categorized into three sub-segments: bare metal stents, drug eluting stents, and bio-absorbable stents. Catheters have been further categorized into angiography catheters, intravascular ultrasound (IVUS) catheters, percutaneous transluminal coronary angioplasty (PTCA) guiding catheters, and pulmonary artery catheters. Percutaneous transluminal coronary angioplasty (PTCA) balloons have been subdivided into normal balloons, cutting balloons, scoring balloons, and drug eluting balloons. The imaging systems interventional cardiology devices market is subdivided into intravascular ultrasound (IVUS) systems, fractional flow reserve (FFR) systems, and optical coherence tomography (OCT) systems. Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.

Read the Present Market Analysis of Interventional Cardiology Devices at: http://www.transparencymarketresearch.com/interventional-cardiology-devices.html

Geographically, the interventional cardiology devices market has been categorized into six regions: North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia-Pacific comprises China, India, and Rest of Asia-Pacific. Latin America comprises Brazil, Mexico, and Rest of Latin America. Middle East and North Africa comprises Saudi Arabia, the United Arab Emirates and Rest of MENA. The recommendations section included in the report would assist existing players to expanding their market share and new companies in establishing their presence in the interventional cardiology devices market. The report also profiles major players in the interventional cardiology devices market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Laboratories, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis Corporation, Medtronic, plc, St. Jude Medical, Inc., Smiths Medical, and Terumo Medical Corporation.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2022 Outlook: Big Opportunities for Interventional Cardiology Devices Market in Emerging Nations here

News-ID: 426923 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Interventional

Global Interventional Cardiology Market (2014-2022)
Market Research Report Store offers a latest published report on Interventional Cardiology Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Interventional Cardiology players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Interventional Cardiology with respect to individual
Interventional Oncology Market By Top Players -
Global Interventional Oncology Market Analysis According to Verified Market Research, the Global Interventional Oncology Market was valued at USD 1.78 Billion in 2018 and is projected to grow at a CAGR of 6.83% to reach USD 2.96 Billion by 2026, over the forecast period. What is Interventional Oncology? Interventional oncology deals with the diagnosis and treatment of cancer using minimally invasive procedures that are performed under image guidance. Interventional oncology is used to
Interventional Image-Guided Systems Market Report 2018: Segmentation by Product …
Global Interventional Image-Guided Systems market research report provides company profile for St. Jude Medical, Neusoft, Konica Minolta, Samsung Medison, Shimadzu, BenQ Medical Technology, Asahi Roentgen, GE Healthcare, Olympus, Philips Healthcare, Siemens Healthineers, Toshiba Medical Systems and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Interventional Neurology Market Global Outlook 2024
Factors such as increasing prevalence of brain aneurysms, and stroke, government programs to decrease the burden of traumatic brain injury, technological advancements plugging treatment gaps and availability of reimbursement are driving demand for neurointerventional devices. However, high cost and negative perception about neurointerventional devices is impacting the demand negatively. Companies are therefore, adopting different strategies such as providing FDA approved on-site training, strategic collaborations, and technology upgrades in order to
Global Interventional Neurology Market - Industry Overview
Market players need to address demand-shift in devices and procedural techniques The global Interventional neurology market is undergoing a demand-shift in terms of products and techniques to treat stroke and aneurysms. For instance, demand for bare platinum coils is growing at a rapid pace as compared to that for coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum
Interventional Cardiology & Peripheral Vascular Devices Market
Interventional Cardiology & Peripheral Vascular Devices Market size is projected to experience significant growth from 2017 to 2024. Interventional cardiology & peripheral vascular devices market size should foresee substantial growth due to growing ageing population and amplified prevalence of heart disorders over the last few decades. Rising need for minimally invasive procedures and increasing technological advancement will drive the business size. According to American College of Cardiology, cardiovascular disease accounts